tiprankstipranks
Instadose Pharma (INSD)
OTHER OTC:INSD
US Market
INSD
Instadose Pharma
RESEARCH TOOLSreports

Instadose Pharma (INSD) Financial Statements

18 Followers

Instadose Pharma Financial Overview

Instadose Pharma's market cap is currently $532.00. The company's EPS TTM is $-0.0039; its P/E ratio is -0.02; Instadose Pharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Nov 21Nov 20Nov 19Nov 18Nov 17
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00-$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00-$ 0.00
Operating Income$ -462.02K$ -25.66K$ -23.27K$ -23.54K$ -31.95K
EBITDA$ -100.43K$ -5.87K$ -23.27K-$ -31.95K
Net Income$ -589.00K$ -33.31K$ -38.58K--
Balance Sheet
Cash & Short-Term Investments$ 0.00$ 84.00$ 84.00$ 133.00$ 1.40K
Total Assets$ 3.00K$ 84.00$ 84.00$ 133.00$ 1.40K
Total Debt$ 0.00$ 0.00$ 55.66K$ 32.73K$ 11.90K
Net Debt$ 0.00$ -84.00$ 55.58K$ 32.60K$ 10.50K
Total Liabilities$ 127.02K$ 206.80K$ 107.02K$ 44.52K$ 16.88K
Stockholders' Equity$ -127.02K$ -106.94K$ -97.52K$ -44.38K$ -15.48K
Cash Flow
Free Cash Flow$ -83.00$ -83.00$ 277.00$ -4.16K$ -26.75K
Operating Cash Flow$ -83.00$ -83.00$ 277.00$ -4.16K$ -26.75K
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 0.00$ 254.00$ 428.00$ 2.85K$ 16.54K
Currency in USD

Instadose Pharma Earnings and Revenue History

Income Statement >

Instadose Pharma Debt to Assets

Balance Sheet >

Instadose Pharma Cash Flow

Cash Flow >

Instadose Pharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >